The three biggest names in payments all made major moves on AI agent infrastructure in the same week, signaling a new front in the payments war.
The DIRECT ANGIO randomised clinical trial by Benjamin Gory and colleagues1 in The Lancet Neurology was designed to test a biologically compelling premise: that a direct transfer to angiography suite ...